Cirasino et al studied factors that could be used to identify patients undergoing lung resection for lung cancer who need allogenic blood transfusion. A person likely to use blood perioperatively might benefit from measures to reduce the need for allogenic units such as autologous blood collection, erythropoietin, and/or hemodilution. The authors are from Milan and Pavia in Italy.
